Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves’ ophthalmopathy
Authors:
- 2 August 2006
- journal article
- research article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 61 (1) , 45-51
Abstract
A prospective, randomised and single blind clinical trial was designed to compare intravenous methylprednisolone pulse (IVGC) with oral methylprednisolone (OGC) monotherapy in terms of effectiveness and tolerability in Graves' ophthalmopathy (GO). Fifty-two consecutive patients with untreated, moderately severe and active GO were randomly treated with either IVGC or OGC therapy for 12 weeks. IVGC therapy achieved a more rapid and significant improvement than OGC therapy according to clinical activity score (p < 0.01), proptosis (p < 0.038), lid width (p < 0.0001), extraocular muscle changes (p < 0.02), optic neuropathy. (p < 0.001), intraocular pressure (p < 0.04), visual acuity (p < 0.03), quality of life (p < 0.0001) and treatment response (p < 0.001). Diplopia was significantly improved in two groups but there was no difference between them (p < 0.6). Heavy smokers indicated alteration of ophthalmic signs with increased thyroid stimulating hormone (TSH)-receptor antibody during the therapy. In conclusion, IVGC therapy was more effective and better tolerated than OGC therapy in the management of GO.Keywords
This publication has 24 references indexed in Scilit:
- Randomized, Single Blind Trial of IntravenousversusOral Steroid Monotherapy in Graves’ OrbitopathyThe Journal of Clinical Endocrinology & Metabolism, 2005
- Assessing quality of life in Australian patients with Graves' ophthalmopathyBritish Journal of Ophthalmology, 2004
- The Measurement of Change in Graves' OphthalmopathyThyroid®, 1998
- Intravenous Methylprednisolone Pulse Therapy in the Treatment of Graves' OphthalmopathyHormone and Metabolic Research, 1998
- Relation between Therapy for Hyperthyroidism and the Course of Graves' OphthalmopathyNew England Journal of Medicine, 1998
- Quality of Life in Patients with Graves' Ophthalmopathy is Markedly Decreased: Measurement by the Medical Outcomes Study InstrumentThyroid®, 1997
- Intravenous Immunoglobulin versus Corticosteroid in Treatment of Graves' OphthalmopathyThyroid®, 1997
- High-Dose Intravenous Steroid Pulse Therapy in Thyroid-Associated Ophthalmopathy.Endocrine Journal, 1996
- Intravenous Methylprednisolone Pulse Therapy for Graves' Ophthalmopathy.Endocrine Journal, 1993
- Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.BMJ, 1988